Q3 earnings season made two strategic income holdings even more attractive, but for opposite reasons. Discover more in this analysis.
Why BTI Stock advanced +0.74% Today — RQD Quant Desk Flash
British American Tobacco Industries p.l.c. ADR (BTI) carries a Roarable Rating of C+ (Hold) with 66/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is BTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, British American Tobacco Industries p.l.c. ADR (NYSE: BTI) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 66/100 at a spot price of $61.52 (+0.74% 1D, market cap $131.93B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 12/20. Across 1016 tracked Health Care issuers, BTI ranks #114 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does BTI compare to MO and PM in the Health Care sector?
▼
Within the Health Care sector (Medicinal Chemicals and Botanical Products), BTI carries a Roarable C+ (66/100 RQD), trailing P/E of 32.8x, gross margin of —, and ROIC of 9.9%. By comparison, MO (Altria Group Inc.) holds a A grade (89/100 RQD, P/E 18.4x, ROIC 48.4%, cap $128.15B) and PM (Philip Morris International Inc) posts a A- grade (81/100 RQD, P/E 28.6x, ROIC 45.3%, cap $324.98B). Among the 5-stock peer group, MO leads on earnings multiple (18.4x) while MO leads on capital efficiency (48.4% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for BTI?
▼
For British American Tobacco Industries p.l.c. ADR (BTI), key quantitative strengths include Clean SEC annual filing review with no major hidden accounting time-bombs. and sector rank #114 in Health Care, while primary risk factors center on Broader market pullbacks can still drag down strong stocks in the short run. and implied 5-year growth hurdle of 25.3%/yr. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.74 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
20D Institutional Volume Accumulation (±3.2% realized swing band)
Capital intensity & 13.9% operating margin leave 9 pts on the table
⚔️ Adversarial Opposing Case: Why the BTI Bull Thesis Could Fail
Even with a 66/100 (C+) score, BTI faces multiple-compression risk if 32.8x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Broader market pullbacks can still drag down strong stocks in the short run.
Dilution & Margin Drag: Cannibal Buyback (-1.24% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($56.68) or 200D SMA ($59.17) invalidates the momentum regime and cuts Target Base ($63.73) toward Bear Floor ($49.71).
Why BTI Stock advanced +0.74% Today — RQD Quant Desk Flash
British American Tobacco Industries p.l.c. ADR (BTI) advanced +0.74% to $61.52, trading at 63% of its 52-week range ($51.8 – $67.3). Solid steady margins (10% return on capital), mixed timing at 33x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 63% of its 52-week range ($51.8 – $67.3) with RSI-14 at 65.7 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±3.2% around $61.52 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C+ (Hold) backed by 52% gross margin and $2.9B annual free cash flow.
A 38% yield sounds like a jackpot until you see what is actually funding it. Six popular income stocks are flashing warning signs that most dividend investors overlook until a cut hits their account.
https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-24-velo-nicotine-pouches
Tobacco, beer, and spirits stocks promise reliable income through any downturn, but the safety picture behind each payout varies so widely that picking the wrong one could cost you more than the dividend is worth.
https://www.gov.uk/government/news/under-18-sales-ban-extended-to-nicotine-products-and-all-vapes
Global Fund A Shares (without sales charge) posted a return of 2.10% in third quarter 2026. Read more here.
Four household names spread across pipelines, tobacco, banking, and consumer staples are paying yields that most blue chips never come close to, but a big yield number means nothing if the cash behind it runs dry.
With Treasury yields north of 5%, the bar for dividend stocks has never been higher, yet five companies are clearing it with cash-covered payouts and decades of consecutive raises behind them.
Scheduled RQD Strong Buys & Whale Accumulation Briefing (BTI Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
BTI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. 0.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BTI today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BTI. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BTI)
1. Head-to-Head Health Care Peer Comparison (BTI vs. MO, PM, DFTX, RGC)
Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, British American Tobacco Industries p.l.c. ADR (BTI) ranks #114 by composite RQD confidence (66/100, grade C+) and #16 by equity capitalization ($131.93B). Within this direct 5-issuer industry benchmark cohort, MO leads on earnings valuation at 18.4x trailing P/E, while MO leads on capital efficiency and profitability with 48.4% ROIC and 62.5% gross margin. MO currently holds the highest overall quantitative score in the immediate peer group at 89/100 (A) compared with BTI at 66/100 (C+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BTI
ACTIVE
British American Tobacco Industries p.l.c. ADR | C+ | 66/100 | 32.8x | — | 9.9% | +0.74% | $131.93B | Benchmark Subject |
| MO Altria Group Inc. | A | 89/100 | 18.4x | 62.5% | 48.4% | +1.67% | $128.15B | /mo-vs-bti → |
| PM Philip Morris International Inc | A- | 81/100 | 28.6x | 67.1% | 45.3% | +0.14% | $324.98B | /pm-vs-bti → |
| DFTX Definium Therapeutics Inc. | D+ | 52/100 | — | — | -32.2% | -4.29% | $5.10B | /dftx-vs-bti → |
| RGC Regencell Bioscience Holdings Limited | D- | 38/100 | — | — | — | -2.19% | $3.40B | /rgc-vs-bti → |
2. BTI Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics
TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOTBritish American Tobacco Industries p.l.c. ADR (BTI) operates in Medicinal Chemicals and Botanical Products (Health Care) with an equity capitalization of $131.93B, trailing P/E of 32.8x, forward P/E of 30.5x, and EV/EBITDA of 21.0x. Operating profitability registers a gross margin of —, operating margin of 13.9%, net profit margin of 10.9%, ROIC of 9.9%, and free cash flow yield of 2.21%, alongside an Altman Z-Score of 3.74 and Piotroski F-Score of 7/9.
3. BTI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs BTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, British American Tobacco Industries p.l.c. ADR (NYSE: BTI) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 66/100 at a spot price of $61.52 (+0.74% 1D, market cap $131.93B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 12/20. Across 1016 tracked Health Care issuers, BTI ranks #114 in composite RQD confidence.
How does BTI compare to MO and PM in the Health Care sector?
Within the Health Care sector (Medicinal Chemicals and Botanical Products), BTI carries a Roarable C+ (66/100 RQD), trailing P/E of 32.8x, gross margin of —, and ROIC of 9.9%. By comparison, MO (Altria Group Inc.) holds a A grade (89/100 RQD, P/E 18.4x, ROIC 48.4%, cap $128.15B) and PM (Philip Morris International Inc) posts a A- grade (81/100 RQD, P/E 28.6x, ROIC 45.3%, cap $324.98B). Among the 5-stock peer group, MO leads on earnings multiple (18.4x) while MO leads on capital efficiency (48.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for BTI?
For British American Tobacco Industries p.l.c. ADR (BTI), key quantitative strengths include Clean SEC annual filing review with no major hidden accounting time-bombs. and sector rank #114 in Health Care, while primary risk factors center on Broader market pullbacks can still drag down strong stocks in the short run. and implied 5-year growth hurdle of 25.3%/yr. Institutional options positioning shows a 50% call / 50% put premium split.
Where is BTI trading relative to its 50-day, 200-day, and 52-week technical levels?
BTI last traded at $61.52 (+0.74% on volume of 4,821,500 shares), positioning the stock +8.54% above its 50-day simple moving average ($56.68) and +3.97% above its 200-day simple moving average ($59.17). Across its 52-week range of $51.80 to $67.30, BTI sits at the 62.7% percentile with a 14-day RSI of 65.7 (BULLISH MOMENTUM) and an implied next-earnings move of ±3.2% ($59.55 to $63.49).
BTI Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is BTI stock moving today?
Why BTI Stock advanced +0.74% Today — RQD Quant Desk Flash. Solid steady margins (10% return on capital), mixed timing at 33x P/E—hold if owned, no rush to chase.
BTI — British American Tobacco Industries p.l.c. ADR: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, BTI scores 66 out of 100 (letter grade C+, verdict "Roarable Hold — Upper Neutral / Watch for Breakout"). The five pillar scores are:
- Fundamental Cash Engine: 11 / 20. Per the Roarable RQD rating, this pillar reflects ROIC of 9.9% and an FCF yield of 2.21%. Implication: returns on capital are positive but moderate, and the cash yield at the current price is thin, which limits the margin of safety on valuation.
- Whale 13F Flow: 14 / 20. Per the Roarable RQD rating, this pillar reflects institutional accumulation and options positioning. Implication: institutional positioning is a modest supportive factor, though the underlying 13F detail is not itemized in the source data.
- Insider Conviction: 12 / 20. Per the Roarable RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. Implication: insider signals are neutral-to-mildly-supportive without a strong conviction signal.
- Macro Regime Fit: 13 / 20. Per the Roarable RQD rating, this pillar reflects a beta of 1.05 and sector sensitivity. Implication: the stock moves roughly in line with the market, so it neither cushions nor amplifies broad swings meaningfully.
- Forensic Balance Sheet: 16 / 20. Per the Roarable RQD rating, this pillar reflects Altman Z 3.74, Piotroski F 7/9, and Debt/Equity 0.39. Implication: this is the strongest pillar, indicating balance sheet resilience.
Taken together, the rating points to a stock whose balance sheet is its strongest feature, while valuation (trailing P/E of 32.8 against a 2.21% FCF yield) and moderate returns temper upside. The "Watch for Breakout" label suggests the rating framework sees potential for re-rating, but the source data does not specify the trigger.
Snapshot
Business
Per the profile, British American Tobacco Industries p.l.c. Common Stock ADR (BTI) is a NYSE-listed issuer in the Health Care sector, within the Medicinal Chemicals and Botanical Products industry. Per the profile, its market capitalization is $131.9B. Not available in source data: product lines, customer segments, and revenue model details.
Open Questions
- What are the revenue, earnings, and cash flow figures by period, since the financials section is empty?
- What drives the gross margin figure of 0% in the market data, and is it a reporting artifact?
- What specific institutional, insider, or Congressional transactions make up the whale and insider pillar scores?
- What catalyst would trigger the "Watch for Breakout" condition the verdict label references?
- What analyst consensus and price targets exist, given that no analyst data was supplied?
BTI Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for British American Tobacco Industries p.l.c. ADR (BTI) • Click "Debate This Headline" to argue it in the Roar Pit below
Q3 earnings season made two strategic income holdings even more attractive, but for opposite reasons. Discover more in this analysis.
A 38% yield sounds like a jackpot until you see what is actually funding it. Six popular income stocks are flashing warning signs that most dividend investors overlook until a cut hits their account.
https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-24-velo-nicotine-pouches
Tobacco, beer, and spirits stocks promise reliable income through any downturn, but the safety picture behind each payout varies so widely that picking the wrong one could cost you more than the dividend is worth.
https://www.gov.uk/government/news/under-18-sales-ban-extended-to-nicotine-products-and-all-vapes
Global Fund A Shares (without sales charge) posted a return of 2.10% in third quarter 2026. Read more here.
Four household names spread across pipelines, tobacco, banking, and consumer staples are paying yields that most blue chips never come close to, but a big yield number means nothing if the cash behind it runs dry.
BTI Bull vs. Bear Conversation Board — What's Your Call at $61.52?
🔥 Official Bull vs. Bear Debate: Is BTI (C+ • RQD 66/100) a Buy at $61.07?
Welcome to the BTI (British American Tobacco Industries p.l.c. ADR) Roar Pit. Current RQD Composite is 66/100 (Roarable Hold — Upper Neutral / Watch for Breakout) in Medicinal Chemicals and Botanical Products. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (32.8x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on BTI — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on BTI, but look at what you are paying: 32.8x trailing P/E with tightening sector spreads. Unless British American Tobacco Industries p.l.c. ADR expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
BTI cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on BTI, the market is fixating on short-term headline noise in Medicinal Chemicals and Botanical Products and ignoring the balance sheet and cash flow trajectory. At $61.07 (52-wk range $51.80 - $67.30), any beat on forward guidance forces shorts and underweight funds to chase.